Lyra Therapeutics, Inc.

NASDAQ:LYRA

0.172 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -93.435-62.68-55.278-43.513-22.127-16.306-6.029
Depreciation & Amortization 0.4710.2781.0671.0010.0950.0270.082
Deferred Income Tax 000-2.422000
Stock Based Compensation 6.7165.8875.4472.771.8130.2440.406
Change In Working Capital 0-4.8854.55513.922-0.8792.1140.079
Accounts Receivables 0000000.164
Inventory 0000000
Accounts Payables -1.8870.45-2.4112.350.345-0.2050.134
Other Working Capital 0-5.3356.96611.572-1.2242.319-0.055
Other Non Cash Items 16.237-1.9040.8242.422-0.0450.167-1.178
Operating Cash Flow -70.011-63.304-43.385-25.82-21.143-13.754-6.64
Investing Activities:
Investments In Property Plant And Equipment -2.338-1.047-0.164-3.385-1.775-0.211-0.037
Acquisitions Net 0000000
Purchases Of Investments -47.949-122.423-64.8420000
Sales Maturities Of Investments 130.592110.88600000
Other Investing Activites 0-0-64.8420000
Investing Cash Flow 80.305-12.584-65.006-3.385-1.775-0.211-0.037
Financing Activities:
Debt Repayment 0000000.5
Common Stock Issued 8.81869.242100.4950.60459.8920.1110.012
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 8.531-3.551-4.2380.35927.811-0.11557.713
Financing Cash Flow 8.53165.69196.2570.35987.703-0.11529.213
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 18.825-10.197-12.134-28.84664.785-14.0822.536
Cash At End Of Period 42.5723.74533.94246.07674.92210.13724.217